Targeting PINK1 Using Natural Products for the Treatment of Human Diseases

Biomed Res Int. 2021 Oct 30:2021:4045819. doi: 10.1155/2021/4045819. eCollection 2021.

Abstract

PINK1, also known as PARK6, is a PTEN-induced putative kinase 1 that is encoded by nuclear genes. PINK1 is ubiquitously expressed and regulates mitochondrial function and mitophagy in a range of cell types. The dysregulation of PINK1 is associated with the pathogenesis and development of mitochondrial-associated disorders. Many natural products could regulate PINK1 to relieve PINK1-associated diseases. Here, we review the structure and function of PINK1, its relationship to human diseases, and the regulation of natural products to PINK1. We further highlight that the discovery of natural PINK1 regulators represents an attractive strategy for the treatment of PINK1-related diseases, including liver and heart diseases, cancer, and Parkinson's disease. Moreover, investigating PINK1 regulation of natural products can enhance the in-depth comprehension of the mechanism of action of natural products.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Products / metabolism
  • Biological Products / pharmacology*
  • Disease
  • Drug Therapy / methods
  • Humans
  • Mitochondria / metabolism
  • Mitochondrial Diseases / drug therapy
  • Mitophagy
  • Mutation
  • Protein Kinases / drug effects*
  • Protein Kinases / genetics
  • Protein Kinases / metabolism*
  • Protein Kinases / physiology
  • Ubiquitin-Protein Ligases / metabolism

Substances

  • Biological Products
  • Ubiquitin-Protein Ligases
  • Protein Kinases
  • PTEN-induced putative kinase